Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

por Wedelin, C., Björkholm, M., Holm, G., Ogenstad, S., Johansson, B., Mellstedt, H.
Publicado 1982

Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.

por Askergren, J., Björkholm, M., Holm, G., Johansson, B., Mellstedt, H., Sundblad, R., Söderberg, G.
Publicado 1980

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

por Karlsson, C, Dahl, H, Lundin, J, Rossmann, E, Brytting, M, Mellstedt, H, Linde, A, Österborg, A
Publicado 2011

NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy

por Mozaffari, F, Lindemalm, C, Choudhury, A, Granstam-Björneklett, H, Helander, I, Lekander, M, Mikaelsson, E, Nilsson, B, Ojutkangas, M-L, Österborg, A, Bergkvist, L, Mellstedt, H
Publicado 2007

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

por Hojjat-Farsangi, M., Daneshmanesh, A. H., Khan, A. S., Shetye, J., Mozaffari, F., Kharaziha, P., Rathje, L.-S., Kokhaei, P., Hansson, L., Vågberg, J., Byström, S., Olsson, E., Löfberg, C., Norström, C., Schultz, J., Norin, M., Olin, T., Österborg, A., Mellstedt, H., Moshfegh, A.
Publicado 2018